Sphenolax® is our flagship Penta-Herbal formulation with TGR5 agonism, DPP-IV inhibition, Alpha-amylase inhibition, dual DYRK1A/GSK-3β inhibition and selective AMP-activated protein kinase (AMPK) activation. Sphenolax® slowly repairs adult pancreas in both human and mouse models of diabetes, providing highly sustained pancreatic beta-cell function.
Upgregulation of UCP-1 in the white adipose tissue resulting in weight loss. Depletes stored fat. Promotes satiety, improves caloric utilisation and gut health. Mitigates hypercholestrolemia. Improves cardiovascular health.
Exigencin mediates blood fibrinolysis. Delays and prevents blood clotting. May acts as blood thinner.
